HLS Therapeutics Inc. (HLTRF)
OTCMKTS · Delayed Price · Currency is USD
3.710
0.00 (0.00%)
At close: Jul 10, 2025
HLS Therapeutics Employees
HLS Therapeutics had 92 employees as of December 31, 2024. The number of employees increased by 1 or 1.10% compared to the previous year.
Employees
92
Change (1Y)
1
Growth (1Y)
1.10%
Revenue / Employee
$617,054
Profits / Employee
-$195,489
Market Cap
112.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
HLS Therapeutics News
- 16 days ago - HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug Plan - Benzinga
- 2 months ago - HLS Therapeutics reports Q1 results - Seeking Alpha
- 2 months ago - HLS Therapeutics Announces Q1 2025 Financial Results - Benzinga
- 4 months ago - HLS Therapeutics GAAP EPS of -$0.10, revenue of $15.5M misses by $0.2M - Seeking Alpha
- 4 months ago - HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid - Benzinga
- 9 months ago - HLS Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $14.08M misses by $6.42M - Seeking Alpha